Sexually transmitted diseases treatment guidelines, 2015

Area of Science:

• Public Health
• Infectious Diseases
• Clinical Medicine

Background:

• Sexually transmitted diseases (STDs) remain a significant public health concern, necessitating regular updates to treatment guidelines.
• Previous STD treatment guidelines were published in 2010, requiring revision to incorporate recent advancements in diagnostics and therapeutics.
• Consultation with experts in STD management is crucial for developing evidence-based treatment recommendations.

Purpose of the Study:

• To update the comprehensive guidelines for the prevention and treatment of sexually transmitted diseases (STDs).
• To provide healthcare providers with current information on diagnostic methods and treatment regimens for various STDs.
• To address emerging issues in STD management, including new pathogens and specific population needs.

Main Methods:

• Convened a panel of STD experts in April 2013 to review existing literature and clinical practices.
• Synthesized current evidence on alternative treatment regimens for Neisseria gonorrhoeae and genital warts.
• Evaluated the utility of nucleic acid amplification tests (NAATs) for diagnosing trichomoniasis and the role of Mycoplasma genitalium.

Main Results:

• Introduced alternative treatment regimens for Neisseria gonorrhoeae and updated options for genital warts.
• Recommended the use of NAATs for diagnosing trichomoniasis and highlighted the implications of Mycoplasma genitalium in urethritis/cervicitis.
• Provided updated HPV vaccine recommendations, counseling messages, and management strategies for transgender individuals.

Conclusions:

• The updated guidelines incorporate significant changes in STD treatment, diagnostics, and prevention strategies.
• These guidelines aim to improve patient outcomes by offering evidence-based approaches to STD care.
• Healthcare providers are encouraged to utilize these updated recommendations for effective STD management and prevention.